Company intelligence / Profile preview

IPGrup

London, England, United Kingdom6sense.com ↗

Ownership: Private
Development stage: Other

Overview

IP Group is a leading UK-based venture capital and intellectual property commercialization firm specializing in early-stage investments in life sciences, deeptech, and cleantech. It has a strong track record supporting university spinouts and high-impact innovations. Its life sciences holdings include clinical-stage biotech firms developing novel therapies for oncology and other indications. The group’s diversified approach provides exposure to multiple clinical programs at various stages through its broad investment pipeline.

Modalities: Small moleculeMonoclonal antibodyGene therapy
Industry: Investors

Partnerships

Collaborates extensively with UK universities and research institutions for technology transferPartners with institutional investors for co-investment rounds

Beyond the preview

Go deeper on IPGrup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPGrup.

Explore the full profile